Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm
NCT ID: NCT01564979
Last Updated: 2012-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
26 participants
INTERVENTIONAL
2012-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Botulinum Toxin A in the Treatment of Hemifacial Spasm
NCT03306940
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
NCT03508882
Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
NCT04589364
Botulinum Toxin A for the Treatment of Keratoconus
NCT01691651
Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
NCT00370734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preseptal
preseptal injection of botulinum toxin type A
botulinum toxin type A (Botox)2.5 units, 5 points
pretarsal
pretarsal injection of Botulinum toxin type A
Botulinum toxin type A 2,5 units, 5 points
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preseptal injection of botulinum toxin type A
botulinum toxin type A (Botox)2.5 units, 5 points
pretarsal injection of Botulinum toxin type A
Botulinum toxin type A 2,5 units, 5 points
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* ocular surface disorders
* tear disorders
* evidence of infection at or around eyelids
* pregnant woman
* other neurologic disease, i.e. OMG
* coagulopathy or treatment with thrombolytic agent
* treatment with aminoglycosides, chloroquine, hydroxychloroquine
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
kitthisak kitthaweesin
Assoc Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
kitthisak kithaweesin, MD
Role: PRINCIPAL_INVESTIGATOR
Khon Kaen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Khon Kaen University
Muang, Changwat Khon Kaen, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Price J, O'Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol. 1993 Mar;13(1):67-71.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KTS-001-BTX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.